Suchergebnisse - "Nicholas, Jacqueline"

PubPharm (8)

1

Accelerometry measures of physical activity and sedentary behavior : Associations with cognitive functioning in MS

enthalten in: Multiple sclerosis and related disorders | 2023

von Manglani, H. | Phansikar, M. | Duraney, E. | +5

2

Efficacy of nabiximols oromucosal spray on spasticity in people with multiple sclerosis : Treatment effects on Spasticity Numeric Rating Scale, muscle spasm count, and spastic muscle tone in two randomized clinical trials

enthalten in: Multiple sclerosis and related disorders | 2023

von Nicholas, J. | Lublin, F. | Klineova, S. | +5

3

Impact of mindfulness training on emotion regulation in multiple sclerosis : Secondary analysis of a pilot randomized controlled trial

enthalten in: Rehabilitation psychology | 2022

von Duraney, E. | Fisher, M. | Manglani, H. | +3

4

Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2022

von Hauser, S. | Cross, A. | Winthrop, K. | +17

5

Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA) : a randomised, controlled, open-label, phase 3b trial

enthalten in: The Lancet. Neurology | 2022

von Foley, J. | Defer, G. | Ryerson, L. | +98

CommentIn: Lancet Neurol. 2022 Jul;21(7):579-581. - PMID 35483388

6

Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis : APLIOS, a randomized phase-2 study

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2022

von Bar-Or, A. | Wiendl, H. | Montalban, X. | +30

7

Effects of 4-week mindfulness training versus adaptive cognitive training on processing speed and working memory in multiple sclerosis

enthalten in: Neuropsychology | 2020

von Manglani, H. | Samimy, S. | Schirda, B. | +2

8

Relapse rates in patients with multiple sclerosis treated with fingolimod : Subgroup analyses of pooled data from three phase 3 trials

enthalten in: Multiple sclerosis and related disorders | 2016

von Derfuss, T. | Ontaneda, D. | Nicholas, J. | +2

1
[1]